1. Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies.5 M K' f# {' W$ h. {7 ? http://www.ncbi.nlm.nih.gov.prox ... f+IVIG+dalakas+2002, o! A0 z' z, y3 {* t# Y$ |! }5 v, T
2. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome.% k% B# t7 ]8 c- M$ W: o http://www.ncbi.nlm.nih.gov.prox ... Barr%C3%A9+syndrome. M# i+ W% g, q: k7 D, a+ k5 F2 V. K6 k
3. IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses. . w- |( |! ]- _http://www.ncbi.nlm.nih.gov.prox ... and+IgG3+subclasses
发表于 2013-9-4 05:53
发表于 2013-9-5 15:02
